
Johnson & Johnson has reached an agreement to ship as many as 400 million doses of their COVID-19 vaccine to …

AstraZeneca have revised their findings from the US study AZD1222 of their COVID-19 vaccine, announcing a 76% efficacy against symptoms …

The last week has seen its fair share of COVID-19 vaccine developments; Bharat Biotech’s candidate was found to be 81% …

Bharat Biotech’s COVID-19 vaccine candidate has shown an interim efficacy of 81% in a Phase III trial, the company announced …

A single dose of the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine reduces UK hospitalisations in over-80s by 80%, a Public Health …

In the last week, a number of COVID-19 new vaccine developments have been made. Pfizer and BioNTech’s vaccine has proven …

The past week has continued to see positive COVID-19 vaccine news; a WHO panel approved the Oxford-AstraZeneca vaccine for all …

The FDA has put Inovio’s planning stages for the final trials of its coronavirus vaccine on hold as the regulator …

The coronavirus news this week focuses on AstraZeneca’s vaccine candidate, as global trials for itsmuch-hyped vaccine were halted after an …

Two-thirds of Americans say they will not get vaccinated against COVID-19 when a treatment first becomes available, according to a …

Vaxart has announced the selection of its lead vaccine candidate for COVID-19 by Operation Warp Speed, a program to find …

A British man has been accused of smuggling a fake coronavirus cure into the US and has been federally charged. …